Caption Management’s Legend Biotech LEGN Stock Holding History

Caption Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	45,000 +15,000	+50%	+$405K	0.01%	1044
2026 Q1	$543K	Hold	30,000	–	–	﹤0.01%	1191
2025 Q4	$652K	Buy	30,000 +10,000	+50%	+$286K	﹤0.01%	1187
2025 Q3	$652K	Buy	+20,000	New	+$738K	0.01%	1236
2025 Q1	–	Sell	-50,000	Closed	-$1.63M	–	1816
2024 Q4	$1.63M	Sell	50,000 -10,000	-17%	-$414K	0.02%	777
2024 Q3	$2.92M	Buy	60,000 +35,000	+140%	+$1.86M	0.05%	447
2024 Q2	$1.11M	Sell	25,000 -4,900	-16%	-$226K	0.02%	639
2024 Q1	$1.68M	Buy	29,900 +4,900	+20%	+$295K	0.03%	586
2023 Q4	$1.5M	Sell	25,000 -27,500	-52%	-$1.74M	0.02%	696
2023 Q3	$3.53M	Buy	52,500 +22,500	+75%	+$1.56M	0.05%	420
2023 Q2	$2.07M	Buy	+30,000	New	+$1.96M	0.04%	486
2022 Q3	–	Sell	-47,900	Closed	-$2.63M	–	1701
2022 Q2	$2.63M	Buy	+47,900	New	+$2.02M	0.04%	583
2021 Q4	–	Sell	-30,000	Closed	-$1.52M	–	1783
2021 Q3	$1.52M	Sell	30,000 -15,000	-33%	-$624K	0.02%	882
2021 Q2	$1.85M	Buy	+45,000	New	+$1.53M	0.02%	703

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Caption Management's LEGN Position: Q2 2026 in Review

Caption Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 15,500 shares — an estimated $418K sold.

Caption Management first reported a position in LEGN in Q3 2022 and held it in 6 quarters. The position peaked at $2.52M in Q4 2022. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Caption Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
Caption Management sold 15,500 Legend Biotech shares in Q2 2026, an estimated $418K.
Caption Management first reported a position in Legend Biotech in Q3 2022 and held it in 6 quarters.
Caption Management's Legend Biotech position peaked at $2.52M in Q4 2022.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.